NPPA and central nervous system cancer: It is of note that survival curves showed a worst prognostic for both IDHw and IDHm lower-grade gliomas when the KP enzymes, specifically ACSMD and KYNU, are overexpressed, indicating that KP-derived metabolites might be an effective marker of the outcome prediction in both lower- and high-grade gliomas.